Beckmann Nicolau, Zurbruegg Stefan, Blé François-Xavier
Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland.
ALTEX. 2007;24 Spec No:12-5.
Current techniques to evaluate the efficacy of potential treatments for airways diseases in small animal models are generally invasive and terminal. In this contribution we illustrate the usefulness of magnetic resonance imaging (MRI) to obtain anatomical and functional information of the lung, with the scope of developing a non-invasive approach for the routine testing of drugs in rat models of airways diseases. With MRI, the disease progression can be followed in the same animal. Thus, a significant reduction in the number of animals used for experimentation is achieved, as well as minimal interference with their well-being and physiological status. In addition, MRI has the potential to shorten the duration of the observation period after disease onset since the technique is able to detect changes before these are reflected in invasively determined parameters of inflammation.
目前在小动物模型中评估气道疾病潜在治疗方法疗效的技术通常具有侵入性且是终末期的。在本论文中,我们阐述了磁共振成像(MRI)在获取肺部解剖和功能信息方面的实用性,旨在开发一种非侵入性方法用于气道疾病大鼠模型的药物常规测试。通过MRI,可以在同一只动物身上跟踪疾病进展。因此,用于实验的动物数量显著减少,同时对它们的健康和生理状态的干扰也降至最低。此外,MRI有潜力缩短疾病发作后的观察期,因为该技术能够在炎症的侵入性测定参数反映出变化之前检测到改变。